CannabisNewsBreaks – Therma Bright Inc.’s (TSX.V: THRM) (OTC: THRBF) TherOZap(TM) Technology in Final Stage Testing Against Zika Virus
Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced that it is in the final stages of in vitro testing and awaits the results of the TherOZap(TM) technology against the Zika virus. According to the update, a top research laboratory in Canada is conducting the testing, and Therma Bright expects to report further information as it becomes available. “To date the research lab has done an excellent job following protocol and testing our device with the aim of reporting statistically relevant results,” Therma Bright CEO Rob Fia stated in the news release. “Therma Bright made a…